Kashyap TeleMed.

What does Kashyap TeleMed. do?

Kashyap Tele-Medicines Ltd, a Micro Cap company in the Computers - Software & Consulting industry, reported net sales and net profit of 0 Cr for the quarter ending March 2025. The company, formerly known as Jindal Online.Com Limited, was incorporated in 1995.

Overview:<BR>Kashyap Tele-Medicines Ltd operates in the Computers - Software & Consulting industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>The company was incorporated on 20th February 1995 and was formerly known as Jindal Online.Com Limited. The latest quarterly results reported net sales and net profit of 0 Cr for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 0 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 40 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>Industry P/E: 29 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.00 <BR>Return on Equity: 0.00% <BR>Price to Book: 0.00 <BR><BR>Contact Details:<BR>Address: Pushpawati Building No2 II Flr, Chandanwadi Girgaon Road Mumbai Maharashtra : 400002 <BR>Email: investor.relations@jindalonline.com <BR>Website: http://www.kashyaptele-medicines.com

Has Kashyap TeleMed. declared dividend?

No Dividend History Available

What is the technical trend for Kashyap TeleMed.?

As of December 27, 2024, Kashyap TeleMed's technical trend is bullish, supported by positive MACD and moving averages, although caution is advised due to a bearish monthly RSI signal.

As of 27 December 2024, the technical trend for Kashyap TeleMed has changed from mildly bullish to bullish. The weekly MACD is bullish, supporting the positive trend, while the daily moving averages also indicate a bullish stance. The KST is bullish on both weekly and monthly time frames. However, the monthly RSI shows a bearish signal, which suggests some caution. The Bollinger Bands are mildly bullish on both weekly and monthly charts. Overall, the current technical stance is bullish, with strength primarily driven by the MACD and moving averages, despite the bearish signal from the monthly RSI.

Why is Kashyap TeleMed. falling/rising?

As of 10-Jun, Kashyap Tele-Medicines Ltd's stock price is declining at 8.05, down 1.95%, with a total drop of 16.23% over the last nine days. Despite strong historical returns, recent trends show weakened investor confidence and significant underperformance compared to the broader market.

As of 10-Jun, Kashyap Tele-Medicines Ltd is experiencing a decline in its stock price, currently at 8.05, which represents a decrease of 0.16 or 1.95%. The stock has been underperforming, having fallen consecutively for the last nine days, resulting in a total decline of 16.23% during this period. Additionally, the stock's performance today has underperformed its sector by 3.42%. Despite a strong year-to-date return of 183.45% and a one-year return of 253.07%, the recent trend indicates a significant drop in investor participation, with delivery volume falling by 92.81% compared to the five-day average. There are no positive or negative dashboard factors available to provide further context on the stock's recent movement.<BR><BR>In the broader market context, the stock's short-term performance over the past week shows a decline of 9.35%, contrasting sharply with the Sensex, which has gained 2.05% during the same period. This underperformance relative to the benchmark suggests that investor sentiment towards Kashyap Tele-Medicines Ltd has weakened, contributing to its recent price decline. While the stock has historically shown strong returns, the current trend indicates challenges that may be affecting investor confidence.

Who are the peers of the Kashyap TeleMed.?

Kashyap TeleMed.'s peers include Saven Tech., Titan Intech, Rolta India, Accedere, Infonative Solutions, Tridhya Tech, Yudiz Solutions, Micropro Software, and Mindpool Tech. Their management risks vary from excellent to below average, with Kashyap TeleMed. showing a significantly higher 1-year return of 177.82% compared to its peers.

Peers: The peers of Kashyap TeleMed. are Saven Tech., Titan Intech, Rolta India, Accedere, Infonative Solu., Tridhya Tech, Yudiz Solutions, Micropro Softwar, and Mindpool Tech.<BR><BR>Quality Snapshot: Excellent management risk is observed at Saven Tech. and Titan Intech, while Average management risk is found at Yudiz Solutions and Micropro Softwar, and the rest have Below Average management risk. Growth is Excellent at Titan Intech, Good at Infonative Solu., and Below Average at Saven Tech., Rolta India, Accedere, Tridhya Tech, Yudiz Solutions, Micropro Softwar, and Mindpool Tech. For Capital Structure, Good ratings are seen at Saven Tech., Titan Intech, Accedere, Yudiz Solutions, and Micropro Softwar, while the rest have Below Average ratings.<BR><BR>Return Snapshot: Rolta India has the highest 1-year return at -46.53%, while Titan Intech has the lowest at -63.19%. Kashyap TeleMed.'s 1-year return of 177.82% is significantly higher than both. Additionally, several peers, including Titan Intech, Rolta India, Accedere, and Mindpool Tech, have negative six-month returns.

Who are in the management team of Kashyap TeleMed.?

As of March 2022, the management team of Kashyap TeleMed includes Amit Agrawal (Managing Director), Surabhi Agrawal, Amrita Khetan, Devkinandan Sharma, Raghav Agrawal, Mayank Khetan (all Directors), and Paritosh Trivedi (Company Secretary & Compliance Officer). Each member contributes to the company's governance and strategic direction.

As of March 2022, the management team of Kashyap TeleMed includes the following individuals:<BR><BR>1. Amit Agrawal - Managing Director<BR>2. Surabhi Agrawal - Independent Director<BR>3. Amrita Khetan - Director<BR>4. Devkinandan Sharma - Independent Director<BR>5. Raghav Agrawal - Director<BR>6. Mayank Khetan - Independent Director<BR>7. Paritosh Trivedi - Company Secretary & Compliance Officer<BR><BR>Each member plays a crucial role in the governance and strategic direction of the company.

Who are the top shareholders of the Kashyap TeleMed.?

The top shareholders of Kashyap TeleMed are Jindal Worldwide Limited with 31.25%, Amitara Industries Private Limited with 19.01%, and individual investors holding 30.92%. There are no pledged promoter holdings, and the company is not held by mutual funds or foreign institutional investors.

The top shareholders of Kashyap TeleMed include Jindal Worldwide Limited, which holds the largest stake at 31.25%. Following that, Amitara Industries Private Limited is the highest public shareholder with a 19.01% stake. Additionally, individual investors collectively hold 30.92% of the company. Notably, there are no pledged promoter holdings, and the company is not held by any mutual funds or foreign institutional investors.

How big is Kashyap TeleMed.?

As of 24th July, Kashyap Tele-Medicines Ltd has a market capitalization of 38.00 Cr, classifying it as a Micro Cap company, with recent net sales of 0.20 Cr and a net loss of 0.01 Cr over the latest four quarters. Data for shareholder's funds and total assets is unavailable.

As of 24th July, <BR><BR>Market Cap: Kashyap Tele-Medicines Ltd has a market capitalization of 38.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 0.20 Cr. The sum of Net Profit for the latest 4 quarters shows a loss of 0.01 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is the latest annual period. However, data for Shareholder's Funds and Total Assets is unavailable.

When is the next results date for Kashyap TeleMed.?

Kashyap TeleMed will announce its results on 12 November 2025.

Kashyap TeleMed is scheduled to declare its results on 12 November 2025.

How has been the historical performance of Kashyap TeleMed.?

Kashyap TeleMed has shown stable but low net sales, remaining at 0.19 Cr for the last two years, with total operating income mirroring this trend. The company has struggled with profitability, reporting a break-even in Mar'25 after previous losses, and earnings per share have remained at 0.0, indicating ongoing financial challenges.

Answer:<BR>The historical performance of Kashyap TeleMed shows a relatively stable but low level of net sales over the years, with figures remaining at 0.19 Cr in both Mar'25 and Mar'24, and slightly higher at 0.20 Cr in Mar'23, Mar'22, and Mar'19. The total operating income has mirrored the net sales, remaining at 0.19 Cr in Mar'25 and Mar'24, while also being 0.20 Cr in the previous years. The company has not incurred any raw material costs, purchase of finished goods, or power costs during this period. Employee costs have increased from 0.05 Cr in Mar'17 to 0.11 Cr in Mar'25, indicating a gradual rise in operational expenses. However, total expenditure (excluding depreciation) peaked at 0.30 Cr in Mar'22 before decreasing to 0.19 Cr in Mar'25. Operating profit has fluctuated, with a loss of 0.03 Cr in Mar'24 and a break-even point in Mar'25, while profit before tax has remained at 0.00 Cr in Mar'25 and Mar'23, with a loss of 0.03 Cr in Mar'24. The profit after tax has also been stagnant, showing a loss of 0.03 Cr in Mar'24 and no profit in the subsequent years. The earnings per share have remained at 0.0 in Mar'25, reflecting the company's ongoing challenges in achieving profitability. <BR><BR>Breakdown:<BR>Kashyap TeleMed's financial performance has been characterized by consistent but low net sales, which have remained stable at 0.19 Cr for the last two years, with a slight increase to 0.20 Cr in the years prior. The company's total operating income has followed a similar trend, indicating no significant growth. Employee costs have gradually increased, suggesting a rise in operational expenses, while total expenditure has seen a notable decrease from 0.30 Cr in Mar'22 to 0.19 Cr in Mar'25. Despite these changes, the company has struggled with profitability, reporting an operating profit of 0.00 Cr in Mar'25 after a loss in the previous year, and consistently low profit before and after tax figures. The earnings per share have not improved, remaining at 0.0 in Mar'25, which reflects the ongoing difficulties in achieving financial stability and growth.

Which are the latest news on Kashyap TeleMed.?